---
title: "Definium Therapeutics (DFTX) Receives a Buy from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295787298.md"
description: "Wells Fargo analyst Benjamin Burnett reiterated a Buy rating on Definium Therapeutics (DFTX) with a $72.00 price target. The analyst covers the Healthcare sector, including Alkermes and MannKind, boasting a 45.63% success rate. Meanwhile, the broader analyst consensus for DFTX remains a Strong Buy, with an average price target of $63.71."
datetime: "2026-08-13T11:06:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295787298.md)
  - [en](https://longbridge.com/en/news/295787298.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295787298.md)
---

# Definium Therapeutics (DFTX) Receives a Buy from Wells Fargo

In a report released today, Benjamin Burnett from Wells Fargo reiterated a Buy rating on Definium Therapeutics, with a price target of $72.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Burnett covers the Healthcare sector, focusing on stocks such as Alkermes, MannKind, and Insmed. According to TipRanks, Burnett has an average return of 2.2% and a 45.63% success rate on recommended stocks.

Currently, the analyst consensus on Definium Therapeutics is a Strong Buy with an average price target of $63.71.

### Related Stocks

- [DFTX.US](https://longbridge.com/en/quote/DFTX.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [ALKS.US](https://longbridge.com/en/quote/ALKS.US.md)
- [MNKD.US](https://longbridge.com/en/quote/MNKD.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [What Do Definium Therapeutics (DFTX) Phase 3 GAD Results Mean For DT120?](https://longbridge.com/en/news/295821556.md)
- [This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday](https://longbridge.com/en/news/296231890.md)
- [Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'](https://longbridge.com/en/news/295680444.md)
- [Piper Sandler Reaffirms Their Buy Rating on Akebia Therapeutics (AKBA)](https://longbridge.com/en/news/296105482.md)
- [LifeSci Capital Reaffirms Their Buy Rating on Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/296003421.md)